Valproic acid is appropriate in the management of seizures - a common feature in Alpers-Huttenlocher syndrome. However, valproic acid has been shown to cause a rapid progression of liver failure in patients with AHS. For this reason, it is critical to diagnose AHS early to avoid this medication and the detrimental effects it may have on the patient's clinical course.